Literature DB >> 6318952

Cytologic diagnosis of hepatocellular carcinoma by fine-needle aspiration biopsy.

L C Tao, C S Ho, M J McLoughlin, W K Evans, E E Donat.   

Abstract

From 1976 to June 1982, 237 patients with clinical suspicion of hepatic malignant disease underwent guided percutaneous fine-needle aspiration biopsy of the liver. Of these, 12 were diagnosed cytologically as "hepatocellular carcinoma" and this diagnosis was confirmed in the follow-up of all cases. On the basis of the cytomorphologic features observed in the aspirates, the tumor was subclassified into three types; well differentiated, pleomorphic large cell; and poorly differentiated. The various cytologic appearances of different types of hepatocellular carcinoma are presented and illustrated. Cytomorphologically, these three types of hepatocellular carcinoma were distinctly different and their cytomorphologic features were also sufficiently distinctive from those of secondary hepatic cancer to be diagnostic. Guided percutaneous fine-needle aspiration biopsy of the liver appears to be a definitive minimally invasive means of establishing the diagnosis of hepatocellular carcinoma, and promises to be a valuable diagnostic procedure for potentially resectable localized hepatocellular carcinoma.

Entities:  

Mesh:

Year:  1984        PMID: 6318952     DOI: 10.1002/1097-0142(19840201)53:3<547::aid-cncr2820530329>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Focal ultrasound lesions in liver cirrhosis diagnosed as regenerating nodules by fine-needle biopsy. Follow-up of 12 cases.

Authors:  G L Rapaccini; M Pompili; E Caturelli; M Anti; A Aliotta; A Cedrone; E Amadei; A Grattagliano; M M Squillante; C Rabitti
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

2.  Role of ultrasound guided fine needle aspiration biopsy in the diagnosis of hepatocellular carcinoma.

Authors:  G Sbolli; F Fornari; G Civardi; M Di Stasi; L Cavanna; E Buscarini; L Buscarini
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

3.  Diagnostic accuracy of fine-needle aspiration biopsy in patients with hepatocellular carcinoma.

Authors:  C Bru; A Maroto; J Bruix; R Faus; L Bianchi; X Calvet; C Ayuso; R Vilana; R Gilabert; J Rodés
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

4.  Liver aspiration in the diagnosis of hepatocellular carcinoma in the Gambia.

Authors:  A Ajdukiewicz; A Crowden; E Hudson; C Pyne
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

5.  Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis.

Authors:  A Maringhini; M Cottone; E Sciarrino; M P Marcenó; F La Seta; G Fusco; F Rinaldi; L Pagliaro
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

6.  Morphological clues for the diagnosis of small hepatocellular carcinomas.

Authors:  F Kondo; N Hirooka; K Wada; Y Kondo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

7.  Non-imaging-guided fine-needle aspiration of liver lesions: a retrospective study of 279 patients.

Authors:  Yeouda Edoute; Ehud Malberger; Orly Tibon-Fishe; Nimer Assy
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

Review 8.  Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Mirella Fraquelli; Tin Nadarevic; Agostino Colli; Cristina Manzotti; Vanja Giljaca; Damir Miletic; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2022-09-02

Review 9.  Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Tin Nadarevic; Vanja Giljaca; Agostino Colli; Mirella Fraquelli; Giovanni Casazza; Damir Miletic; Davor Štimac
Journal:  Cochrane Database Syst Rev       Date:  2021-10-06

10.  Fine needle aspiration biopsy of liver - an update.

Authors:  David C Chhieng
Journal:  World J Surg Oncol       Date:  2004-03-16       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.